Explore Global Companies & Account Intelligence

Neuro-Sys is a research-intensive and innovative organisation specialising in pharmacology and in advanced in vitro and in vivo models of neurodegenerative diseases, mode of action research, and drug development in the CNS and PNS fields. We provide pharmacological profiles of lead compounds and explore their underlying mechanism of action and studies to determine the neuroprotective activity. We’re dedicated to providing high-level technical expertise in a collaborative relationship with our clients and accompany you along the drug development stages, from preclinical to clinical. Our expertise: › Alzheimer’s disease (AD) › Parkinson’s disease (PD) › Amyotrophic Lateral Sclerosis (ALS or Lou Gehrig’s disease) › Multiple Sclerosis (MS) › Peripheral Neuropathies › Blood Brain Barrier DRUG DEVELOPMENT SERVICES Our experts in drug and pharmaceutical development provide expert guidance on: •The design of your drug discovery development plan (pre-clinical testing in vitro and in vivo models) •The design of your preclinical research programs (in vitro/ in vivo, mode of action) •The preclinical (Pharmacology, PK and ADME) development and early clinical designs (PoC studies) •The writing of research projects, investigator brochures (IB), IMPD, ODD submission (FDA/EMA) in neuro indication

NeuroTick is a company specialising in IT consultancy and development, we're only just starting up and getting things moving so watch this space for updates coming soon!

Neurobit Technologies is a Taiwanese multinational corporation that designs and manufactures comprehensive neuro-otological diagnostic system for better patient care.

NeuroBrain consists of a group of researchers, focused in cutting edge research in Artificial Intelligence and Deep Technology.

Fundada en el 2015, Neurobrand nace con la idea de generar un valor agregado para sus clientes mediante la estructuración, desarrollo e implementación de proyectos estratégicos. El espíritu innovador y de creatividad que caracteriza a Neuobrand, le permite generar valor más allá de lo esperado. Nuestra filosofía está enfocada 100% en nuestros clientes y orientado a la consecución de resultados, entendemos los desafíos que enfrentan a diario, y nos involucramos en cada paso del éxito y su camino. Contamos con una amplia experiencia en el mundo empresarial y de start-ups en sectores como e-commerce, servicios, manufactura, industria alimenticia, consumo masivo, bancario y exportaciones. Nuestros clientes nos ven como un socio estratégico para la consecución de los resultados, así hemos creado en nuestra organización una cultura de crear relaciones con nuestros clientes Eugenia Rodríguez, Directora de Negocios Neurobrand ha logrado expandir los alcances de los proyectos de sus clientes a más de ocho países en la región Latinoamericana y Caribe, así como en Estados Unidos. "Neurobrand, construtyendo juntos proyectos y marcas"

We are on a mission to change the world one brain at a time. We support leaders to develop their 'neurocapability' to lead with the brain in mind. We have a range of online programs - from our nationally accredited Advanced Diploma of Neuroscience of Leadership to smaller bite-sized learning modules. NeuroCapability believes that psychological safety is fundamental to organizational growth and success and that investments that increase psychological safety result in positive ROI for businesses. We measure psychological safety in teams and support organisations to improve leadership capability to provide psychologically safe team climates that are the key ingredient of high performing teams.

neurocare group AG has developed a best practice mental health platform, empowering clinicians to offer their patients, through personalized therapy, the best care for a variety of psychological or neurological conditions with more sustainable clinical outcomes. These therapy plans integrate innovative methods and tools, such as psychotherapy, neuromodulation and sleep hygiene, as well as medication. Following a detailed assessment of the patient's condition, neurocare supports clinicians in developing personalized therapy plans that improve self-regulation, resilience and social skills, while being cost-effective for the healthcare system. The key technology elements of neurocare’s platform are developed in-house, including leading TMS and EEG devices, a cloud-based software platform, as well as an online academy to give professionals the tools and neuroscientific understanding to properly apply these solutions in clinical practice. neurocare’s mental health platform is currently applied throughout the company’s own clinics across the US, the UK, the Netherlands and Australia, as well as in a growing number of third-party clinics.

Neurocenter Finland is a one-stop shop for research in neurosciences and product development. It facilitates innovations and development of new personalized healthcare. A key objective is to create a structure of collaboration and platform for researchers and other stakeholders. Furthermore, it makes relevant information in neurosciences conveniently available. Get in touch with your local expert in regional Brain & Mind network in Helsinki, Turku, Tampere, Jyväskylä, Kuopio or Oulu and join our network! #codedtoconnect

The company Neurochlore is developing an innovative therapeutic strategy to ameliorate developmental brain pathologies. Located Luminy (Marseille), the company has formed close links with internationally recognized scientific experts in some fields of developmental Neurobiology and neurological disorders. Furthermore, extensive collaborations with drug developers and clinical experts in neuro-pediatrics and psychiatry enable Neurochlore to develop and test novel applications for its therapeutic agent. Indeed, Neurochlore has an international patent in the use of a diuretic in the treatment of Autism Spectrum Disorders (ASD) and another syndrome associated with autism. Clinical Research Neurochlore is currently developing a treatment which will be able to ameliorate ASD in children and adolescents. The company has already conducted a successful monocentric study (Lemonnier et al., Translational Psychiatry, 2012) and a multicentric phase II clinical trial in order to confirm the efficacy and tolerance of this new treatment (Lemonnier et al., article in press). This study will be soon followed by a double-blind randomized phase III study that, if successful, will allow to submit a registration application to the European health authorities. Fundamental Research Fundamental research at Neurochlore is organized around a wide range of animal models of ASD and syndromes with associated autism. Research topics are focused on the study of developmental sequence modifications of GABAergic/glutamatergic currents in pathologies, focusing in the periods in utero and during birth. To determine the features of malformed brain currents/networks, a large range of techniques is used including electrophysiological recordings of in vitro slices, in vivo recordings, morphological analysis… The fundamental research is financed by external sources notably the Bettencourt Schueller Foundation.

Neurocle is a leading and innovative deep learning vision software company. Our vision is to make deep learning vision technology more accessible. To realize this vision, we developed three deep learning softwares Neuro-T, Neuro-R and Neuro-X. Neuro-T is designed for non-experts and can create high-quality models with just a few clicks. Neuro-R is a Real-Time Inference Engine that run models created in Neuro-T. Neuro-X is designed for deep learning experts, so that they can manage data and create model easily with intuitive GUI. By providing quick and easy solutions for users with high-quality software, we have entered various industries including manufacturing, medical market and played a key role in proceeding big projects. For more information or to rent our software , go to https://www.neuro-cle.com/.

With three decades of industry experience, Neurocom is a leading, data-driven solution provider offering comprehensive fraud and risk management solutions to payment and financial service providers, and regulated entities, assisting them in meeting regulatory obligations, preventing fraud and mitigating risk.

NeuroDigital Technologies provides innovative Hardware solutions for Tactile Virtual Reality, creating advanced technology for haptics, motion capture and Smart Triggering. Our mission is to provide innovative systems and solutions based on Virtual Reality conceived specifically for troubleshooting unsolved problems requiring touch sense, full tracking and manual interaction. These solutions are addressed to a number of areas spanning Industry, Healthcare, Education, Defense, Advertising, Culture... and of course Entertainment.